Super-Selective Mesenteric Embolization Provides Effective Control of Lower GI Bleeding

Table 1

Demography.

Demography	Number
Gender
(i) Male	12 (67%)
(ii) Female	6 (33%)
Median age	74.50 (range: 59–92)
Comorbidities
(i) Ischaemic heart disease	7 (39%)
(ii) Atrial fibrillation	3 (17%)
(iii) Hypertension	12 (67%)
(iv) Diabetes	6 (33%)
Anticoagulation
(i) Aspirin	6 (33%)
(ii) Aspirin + clopidogrel	3 (17%)
(iii) Warfarin	1 (6%)